AgeneBio Secures $1,000,113 New Funding Round

  • Feed Type
  • Date
    11/19/2013
  • Company Name
    AgeneBio
  • Mailing Address
    11711 North Meridian Street Carmel, IN 46032
  • Company Description
    AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s disease (AD).
  • Website
    http://www.agenebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,113
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy